Persistent hyperinsulinaemic hypoglycaemia of infancy (nesidioblastosis): a report from Kuwait

D G Ramadan1, M H Badawi, M Zaki

  • 1Department of Paediatrics of Sabah, Hospital, Kuwait.

Insights

Persistent hyperinsulinaemic hypoglycaemia (PHHI) in Bedouin children presents with seizures and severe hypoglycemia. Early diagnosis and treatment are crucial for neurodevelopmental outcomes.

Area of Science:

  • Pediatrics
  • Endocrinology
  • Genetics

Background:

  • Persistent hyperinsulinaemic hypoglycaemia (PHHI) is a rare but serious condition.
  • The Bedouin community in Kuwait exhibits a high incidence of PHHI, suggesting a genetic component.
  • PHHI can lead to severe neurological complications if not managed promptly.

Purpose of the Study:

  • To describe the clinical presentation, management, and outcomes of PHHI in Bedouin children.
  • To highlight the high incidence and potential genetic inheritance patterns of PHHI in an inbred community.
  • To emphasize the importance of early diagnosis and intervention for PHHI.

Main Methods:

  • Retrospective case series of nine Bedouin children with PHHI over 13 years.
  • Review of clinical data including presentation, treatment modalities (diazoxide, octreotide, pancreatectomy), and neurodevelopmental outcomes.
  • Analysis of family history to identify inheritance patterns.

Main Results:

  • Nine Bedouin children diagnosed with PHHI, with a high incidence of 1:20,000 in this community.
  • Seizures and severe recurrent hypoglycemia were common presentations, often in the neonatal period.
  • Treatment outcomes varied: diazoxide achieved remission in one, octreotide was successful in another, and four underwent pancreatectomy.
  • Two children had normal neurodevelopment, four experienced mental retardation, and three died.
  • Nesidioblastosis was observed in all surgically treated patients (diffuse in two, localized in two).

Conclusions:

  • PHHI in this Bedouin population has a high incidence and is potentially linked to autosomal recessive inheritance.
  • Prompt diagnosis and management, including medical and surgical options, are vital to prevent severe neurological damage.
  • Genetic counseling is recommended for families with affected siblings due to the possibility of inherited forms of PHHI.

Related Concept Videos

Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Hypoglycemia and Glucagon01:15

Hypoglycemia and Glucagon

Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
Type I Diabetes III: Clinical Manifestations01:19

Type I Diabetes III: Clinical Manifestations

Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
Hyperosmolar Hyperglycemic State01:21

Hyperosmolar Hyperglycemic State

Hyperosmolar Hyperglycemic State, or HHS, is a serious and life-threatening complication of type 2 diabetes mellitus. It is characterized by three main features: severe hyperglycemia, profound dehydration, and elevated serum osmolality, all occurring without significant ketoacidosis.HHS typically develops in older adults or individuals with limited access to fluids. This may result from illness, cognitive impairment, or medications such as diuretics or corticosteroids. These factors reduce...